Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
van den Hof, S.
de Melker, H. E.
Berbers, G. A. M.
van der Kraak, P. H.
and
Conyn-van Spaendonck, M. A. E.
2001.
Antibodies to Haemophilus influenzae Serotype b in The Netherlands a Few Years after the Introduction of Routine Vaccination.
Clinical Infectious Diseases,
Vol. 32,
Issue. 1,
p.
2.
Morris, M
2002.
Oral fluid collection by post—a pilot study of two approaches.
Public Health,
Vol. 116,
Issue. 2,
p.
113.
Morris, Marianne
Cohen, Bernard
Andrews, Nick
and
Brown, David
2002.
Stability of total and rubella-specific IgG in oral fluid samples: the effect of time and temperature.
Journal of Immunological Methods,
Vol. 266,
Issue. 1-2,
p.
111.
Tapia, Milagritos D.
Pasetti, Marcela F.
Cuberos, Lilian
Sow, Samba O.
Doumbia, Mama N.
Bagayogo, Modibo
Kotloff, Karen L.
and
Levine, Myron M.
2006.
Measurement of Tetanus Antitoxin in Oral Fluid.
Pediatric Infectious Disease Journal,
Vol. 25,
Issue. 9,
p.
819.
de Melker, Hester
Berbers, Guy
Hahné, Susan
Rümke, Hans
van den Hof, Susan
de Wit, Ardine
and
Boot, Hein
2006.
The epidemiology of varicella and herpes zoster in The Netherlands: Implications for varicella zoster virus vaccination.
Vaccine,
Vol. 24,
Issue. 18,
p.
3946.
Wallinga, Jacco
Teunis, Peter
and
Kretzschmar, Mirjam
2006.
Using Data on Social Contacts to Estimate Age-specific Transmission Parameters for Respiratory-spread Infectious Agents.
American Journal of Epidemiology,
Vol. 164,
Issue. 10,
p.
936.
Nardone, A.
de Ory, F.
Carton, M.
Cohen, D.
van Damme, P.
Davidkin, I.
Rota, M.C.
de Melker, H.
Mossong, J.
Slacikova, M.
Tischer, A.
Andrews, N.
Berbers, G.
Gabutti, G.
Gay, N.
Jones, L.
Jokinen, S.
Kafatos, G.
de Aragón, M.V. Martínez
Schneider, F.
Smetana, Z.
Vargova, B.
Vranckx, R.
and
Miller, E.
2007.
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.
Vaccine,
Vol. 25,
Issue. 45,
p.
7866.
HOFHUIS, A.
VAN PELT, W.
VAN DUYNHOVEN, Y. T. H. P.
NIJHUIS, C. D. M.
MOLLEMA, L.
VAN DER KLIS, F. R. M.
HAVELAAR, A. H.
and
KORTBEEK, L. M.
2011.
Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995/1996 and 2006/2007.
Epidemiology and Infection,
Vol. 139,
Issue. 4,
p.
530.
VERHOEF, L.
BOOT, H. J.
KOOPMANS, M.
MOLLEMA, L.
VAN DER KLIS, F.
REIMERINK, J.
and
VAN PELT, W.
2011.
Changing risk profile of hepatitis A in The Netherlands: a comparison of seroprevalence in 1995–1996 and 2006–2007.
Epidemiology and Infection,
Vol. 139,
Issue. 8,
p.
1172.
Mollema, Liesbeth
Wijers, Nancy
Hahné, Susan JM
van der Klis, Fiona RM
Boshuizen, Hendriek C
and
de Melker, Hester E
2012.
Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires.
BMC Public Health,
Vol. 12,
Issue. 1,
van Rijckevorsel, Gini GC
Damen, Marjolein
Sonder, Gerard J
van der Loeff, Maarten F Schim
and
van den Hoek, Anneke
2012.
Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.
BMC Infectious Diseases,
Vol. 12,
Issue. 1,
van Lier, Alies
Smits, Gaby
Mollema, Liesbeth
Waaijenborg, Sandra
Berbers, Guy
van der Klis, Fiona
Boot, Hein
Wallinga, Jacco
and
de Melker, Hester
2013.
Varicella zoster virus infection occurs at a relatively young age in the Netherlands.
Vaccine,
Vol. 31,
Issue. 44,
p.
5127.
Exum, Natalie G.
Pisanic, Nora
Granger, Douglas A.
Schwab, Kellogg J.
Detrick, Barbara
Kosek, Margaret
Egorov, Andrey I.
Griffin, Shannon M.
and
Heaney, Christopher D.
2016.
Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.
Current Environmental Health Reports,
Vol. 3,
Issue. 3,
p.
322.
Woestenberg, Petra J.
Tjhie, Jeroen H. T.
de Melker, Hester E.
van der Klis, Fiona R. M.
van Bergen, Jan E. A. M
van der Sande, Marianne A. B.
and
van Benthem, Birgit H. B.
2016.
Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.
BMC Infectious Diseases,
Vol. 16,
Issue. 1,
van den Berg, Oda E.
Stanoeva, Kamelia R.
Zonneveld, Rens
Hoek-van Deursen, Denise
van der Klis, Fiona R.
van de Kassteele, Jan
Franz, Eelco
Opsteegh, Marieke
Friesema, Ingrid H. M.
and
Kortbeek, Laetitia M.
2023.
Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study.
Epidemiology and Infection,
Vol. 151,
Issue. ,
Alexiou, Zoïe Willemijn
van Aar, Fleur
Hoenderboom, Bernice Maria
Morre, Servaas Antonie
and
Heijne, Janneke Cornelia Maria
2024.
Trends inChlamydia trachomatisIgG seroprevalence in the general population of the Netherlands over 20 years.
Sexually Transmitted Infections,
Vol. 100,
Issue. 1,
p.
31.
Postema, Abigail
Ferreira, José A.
van der Klis, Fiona
de Melker, Hester
and
Mollema, Liesbeth
2024.
Investigating sources of non-response bias in a population-based seroprevalence study of vaccine-preventable diseases in the Netherlands.
BMC Infectious Diseases,
Vol. 24,
Issue. 1,
Chisenga, Caroline C
Phiri, Bernard
Ng’ombe, Harriet
Muchimba, Mutinta
Liswaniso, Fraser
Bernshtein, Biana
Cunningham, Adam F
Sack, David
and
Bosomprah, Samuel
2024.
Diagnostic accuracy of saliva-based testing as a Vibrio cholerae surveillance tool among naturally infected patients.
Clinical and Experimental Immunology,